128 related articles for article (PubMed ID: 33613773)
1. Combination of oncolytic adenovirus targeting SATB1 and docetaxel for the treatment of castration-resistant prostate cancer.
Mao L; Yu H; Ma S; Xu Z; Wei F; Yang C; Zheng J
J Cancer; 2021; 12(6):1846-1852. PubMed ID: 33613773
[No Abstract] [Full Text] [Related]
2. Oncolytic virus carrying shRNA targeting SATB1 inhibits prostate cancer growth and metastasis.
Mao LJ; Zhang J; Liu N; Fan L; Yang DR; Xue BX; Shan YX; Zheng JN
Tumour Biol; 2015 Nov; 36(11):9073-81. PubMed ID: 26084613
[TBL] [Abstract][Full Text] [Related]
3. Oncolytic Adenovirus Harboring Interleukin-24 Improves Chemotherapy for Advanced Prostate Cancer.
Mao LJ; Ding M; Xu K; Pan J; Yu H; Yang C
J Cancer; 2018; 9(23):4391-4397. PubMed ID: 30519344
[TBL] [Abstract][Full Text] [Related]
4. [Construction of an oncolytic adenovirus expressing small hairpin RNA and targeting the SATB1 gene].
Mao LJ; Zheng JN; Li W; Wang JQ; Chen JC; Sun XQ
Zhonghua Nan Ke Xue; 2010 Aug; 16(8):679-83. PubMed ID: 21090340
[TBL] [Abstract][Full Text] [Related]
5. Oncolytic adenovirus carrying SPAG9-shRNA enhanced the efficacy of docetaxel for advanced prostate cancer.
Lu M; Xu Z; Wei F; Wang J; Ma S; Kan Y; Li B; Wu C; Mao L
Anticancer Drugs; 2022 Feb; 33(2):142-148. PubMed ID: 34561997
[TBL] [Abstract][Full Text] [Related]
6. Cancer targeting gene-viro-therapy for pancreatic cancer using oncolytic adenovirus ZD55-IL-24 in immune-competent mice.
He B; Huang X; Liu X; Xu B
Mol Biol Rep; 2013 Sep; 40(9):5397-405. PubMed ID: 23666064
[TBL] [Abstract][Full Text] [Related]
7. An armed oncolytic adenovirus ZD55-IL-24 combined with ADM or DDP demonstrated enhanced antitumor effect in lung cancer.
Zhong S; Yu D; Wang Y; Qiu S; Wu S; Liu XY
Acta Oncol; 2010; 49(1):91-9. PubMed ID: 19734998
[TBL] [Abstract][Full Text] [Related]
8. Combination Therapy of Prostate Cancer by Oncolytic Adenovirus Harboring Interleukin 24 and Ionizing Radiation.
Mao LJ; Kan Y; Li BH; Ma S; Liu Y; Yang DL; Yang C
Front Oncol; 2020; 10():421. PubMed ID: 32318337
[TBL] [Abstract][Full Text] [Related]
9. Targeting lung cancer stem-like cells with TRAIL gene armed oncolytic adenovirus.
Yang Y; Xu H; Huang W; Ding M; Xiao J; Yang D; Li H; Liu XY; Chu L
J Cell Mol Med; 2015 May; 19(5):915-23. PubMed ID: 25683371
[TBL] [Abstract][Full Text] [Related]
10. A Triple-Regulated Oncolytic Adenovirus Carrying MicroRNA-143 Exhibits Potent Antitumor Efficacy in Colorectal Cancer.
Luo Q; Song H; Deng X; Li J; Jian W; Zhao J; Zheng X; Basnet S; Ge H; Daniel T; Xu B; Fang L
Mol Ther Oncolytics; 2020 Mar; 16():219-229. PubMed ID: 32123722
[TBL] [Abstract][Full Text] [Related]
11. Combination of oncolytic adenovirus ZD55 harboring TRAIL-IETD-MnSOD and cytokine-induced killer cells against lung cancer.
Jiang R; Zhang Z; Liao X; Huang L; Liao Y; Deng W
Ann Transl Med; 2021 Oct; 9(20):1527. PubMed ID: 34790733
[TBL] [Abstract][Full Text] [Related]
12. Potent antitumor efficacy of ST13 for colorectal cancer mediated by oncolytic adenovirus via mitochondrial apoptotic cell death.
Yang M; Cao X; Yu MC; Gu JF; Shen ZH; Ding M; Yu DB; Zheng S; Liu Xy
Hum Gene Ther; 2008 Apr; 19(4):343-53. PubMed ID: 18355116
[TBL] [Abstract][Full Text] [Related]
13. Potent antitumor activity of oncolytic adenovirus expressing mda-7/IL-24 for colorectal cancer.
Zhao L; Gu J; Dong A; Zhang Y; Zhong L; He L; Wang Y; Zhang J; Zhang Z; Huiwang J; Qian Q; Qian C; Liu X
Hum Gene Ther; 2005 Jul; 16(7):845-58. PubMed ID: 16000066
[TBL] [Abstract][Full Text] [Related]
14. Additive naftopidil treatment synergizes docetaxel-induced apoptosis in human prostate cancer cells.
Ishii K; Matsuoka I; Kajiwara S; Sasaki T; Miki M; Kato M; Kanda H; Arima K; Shiraishi T; Sugimura Y
J Cancer Res Clin Oncol; 2018 Jan; 144(1):89-98. PubMed ID: 29098395
[TBL] [Abstract][Full Text] [Related]
15. A dual-regulated oncolytic adenovirus carrying TAp63 gene exerts potent antitumor effect on colorectal cancer cells.
Luo Q; Liu H; Zhang Z; Basnet S; Dai Z; Li S; Wang Y; Xu B; Ge H
Am J Transl Res; 2017; 9(6):2966-2974. PubMed ID: 28670384
[TBL] [Abstract][Full Text] [Related]
16. Oncolytic Adenovirus with SPAG9 shRNA Driven by DD3 Promoter Improved the Efficacy of Docetaxil for Prostate Cancer.
Lu M; Wei FK; Wu C; Xu ZY; Mao LJ; Yang DR
J Oncol; 2022; 2022():7918067. PubMed ID: 35535313
[TBL] [Abstract][Full Text] [Related]
17. Combination of ZD55-MnSOD therapy with 5-FU enhances antitumor efficacy in colorectal cancer.
Zhang Y; Qin X; Zhang Y; Zhao L; Wang Y; Liu X; Yao L
J Cancer Res Clin Oncol; 2008 Feb; 134(2):219-26. PubMed ID: 17632733
[TBL] [Abstract][Full Text] [Related]
18. Synergistic Anti-tumour Effects of Quercetin and Oncolytic Adenovirus expressing TRAIL in Human Hepatocellular Carcinoma.
Zou H; Zheng YF; Ge W; Wang SB; Mou XZ
Sci Rep; 2018 Feb; 8(1):2182. PubMed ID: 29391509
[TBL] [Abstract][Full Text] [Related]
19. Complete elimination of colorectal tumor xenograft by combined manganese superoxide dismutase with tumor necrosis factor-related apoptosis-inducing ligand gene virotherapy.
Zhang Y; Gu J; Zhao L; He L; Qian W; Wang J; Wang Y; Qian Q; Qian C; Wu J; Liu XY
Cancer Res; 2006 Apr; 66(8):4291-8. PubMed ID: 16618754
[TBL] [Abstract][Full Text] [Related]
20. Suppression of tumor growth by oncolytic adenovirus-mediated delivery of an antiangiogenic gene, soluble Flt-1.
Zhang Z; Zou W; Wang J; Gu J; Dang Y; Li B; Zhao L; Qian C; Qian Q; Liu X
Mol Ther; 2005 Apr; 11(4):553-62. PubMed ID: 15771958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]